Unilever R&D

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Unilever R&D sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed upper quartile by trial count

Unilever R&D: 3 sponsored US clinical trials, 1 recruiting.

Unilever R&D sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Appetite Depressant, with 1 trials.

Upper-quartile sponsor footprint

Unilever R&D sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING NA

The Effect of Cosmetic Formulations on the Appearance of Grey Hair.

NCT07280676
COMPLETED NA

Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation

NCT04155658
COMPLETED NA

Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717)

NCT01306422

Therapeutic Areas

Appetite Depressant 1
Hair Graying 1
Body Weight 1
Overweight 1

What is open in the Unilever R&D pipeline

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Appetite Depressant (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Unilever R&D: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Unilever R&D sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Unilever R&D10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Unilever R&D sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Unilever R&D sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Unilever R&D page

3 registered trials is a research-attention snapshot, not an endorsement of Unilever R&D or any single study.

  • 1 of Unilever R&D's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Appetite Depressant is the condition Unilever R&D studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Appetite Depressant trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Unilever R&D pipeline card: 3 registered trials from official public datasets.Report a data error.